Atrial Fibrillation Clinical Trials in Jonesboro, Arkansas

5 studies are recruiting for atrial fibrillation in Jonesboro, Arkansas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. The Fourth Left Atrial Appendage Occlusion Study

   LAAOS-4 aims to determine if catheter-based endovascular left atrial appendage occlusion prevents ischemic stroke or systemic embolism in participants with atrial fibrillation, who remain at high risk of stroke, despite receiving ongoing treatment with oral anticoagulation.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Arrhythmia Research Group, Jonesboro, Arkansas

   Locations

   150 in total

   Run by

   Hamilton Health Sciences Corporation

   See if you can join NCT05963698 on ClinicalTrials.gov

2. A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation

   The purpose of this study is to assess how safe VARIPULSE pulsed field ablation (PFA) catheter is and how well it works compared to food and drug administration (FDA) approved FARAWAVE PFA catheter in participants with symptomatic persistent atrial fibrillation (PsAF; continuous irregular, rapid he…

   Stage

   Not phased

   Ages

   18 to 80

   Site

   Arrhythmia Research Group, Jonesboro, Arkansas

   Locations

   10 in total

   Run by

   Biosense Webster, Inc.

   See if you can join NCT07523750 on ClinicalTrials.gov

3. A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation

   The purpose of this study is to assess how safe VARIPULSE catheter system is for treatment of a heart rhythm disease called persistent atrial fibrillation (PsAF) in participants who are having a catheter ablation procedure (treat heart rhythm disease). This includes isolation of pulmonary vein and …

   Stage

   Not phased

   Ages

   18 to 80

   Site

   Arrhythmia Research Group, Jonesboro, Arkansas

   Locations

   3 in total

   Run by

   Biosense Webster, Inc.

   See if you can join NCT07527299 on ClinicalTrials.gov

4. Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF

   The primary objective of this clinical investigation is to demonstrate the safety and 12-month effectiveness of pulmonary vein isolation (PVI) and posterior LA wall isolation in the treatment of subjects with symptomatic paroxysmal and persistent atrial fibrillation using the pulsed field ablation …

   Stage

   Not phased

   Ages

   18 to 80

   Site

   St. Bernard's Heart and Vascular Center, Jonesboro, Arkansas

   Locations

   6 in total

   Run by

   Massachusetts General Hospital

   See if you can join NCT06099730 on ClinicalTrials.gov

5. Tracking Results of Ablations to Combat AF Registry Generation 2

   The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation.

   Stage

   Not phased

   Ages

   18 and older

   Site

   St. Bernards Medical Center, Jonesboro, Arkansas

   Locations

   29 in total

   Run by

   AtriCure, Inc.

   See if you can join NCT05111015 on ClinicalTrials.gov